Effects of combustible cigarettes and electronic nicotine delivery systems on immune cell-driven inflammation: Evidences from diabetic patients and multiple low dose streptozotocin-treated diabetic mice.


Journal

Journal of biochemical and molecular toxicology
ISSN: 1099-0461
Titre abrégé: J Biochem Mol Toxicol
Pays: United States
ID NLM: 9717231

Informations de publication

Date de publication:
Sep 2024
Historique:
revised: 14 08 2024
received: 26 02 2024
accepted: 27 08 2024
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 5 9 2024
Statut: ppublish

Résumé

Considering detrimental impacts of combustible cigarettes (CCs) on the exacerbation of diabetes mellitus (DM), a significant number of DM patients have substituted CCs with electronic nicotine delivery systems (ENDS). Herewith, we compared CCs and ENDS-dependent modulation of immune cell-driven inflammation in DM patients who used ENDS (DM

Identifiants

pubmed: 39235091
doi: 10.1002/jbt.23841
doi:

Substances chimiques

Cytokines 0
Streptozocin 5W494URQ81

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e23841

Subventions

Organisme : Foundation for a Smoke-Free World
Organisme : Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Organisme : Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

R. D. Leslie, R. C. W. Ma, P. W. Franks, K. J. Nadeau, E. R. Pearson, M. J. Redondo, Lancet Diabetes Endocrinol. 2023, 11(11), 848.
S. M. Cabrera, A. M. Henschel, M. J. Hessner, Transl. Res. 2016, 167(1), 214.
J. Luo, T. Ning, X. Li, T. Jiang, S. Tan, D. Ma, Biomed. Pharmacother. 2024, 170, 115958.
D. V. Pham, P. H. Park, Arch. Pharm. Res. 2020, 43(10), 997.
M. Begum, M. Choubey, M. B. Tirumalasetty, S. Arbee, M. M. Mohib, M. Wahiduzzaman, M. A. Mamun, M. B. Uddin, M. S. Mohiuddin, Life 2023, 13(11), 2213.
E. Y. M. Lau, E. C. Carroll, L. A. Callender, G. A. Hood, V. Berryman, M. Pattrick, S. Finer, G. A. Hitman, G. L. Ackland, S. M. Henson, Clin. Exp. Immunol. 2019, 197(2), 205.
S. A. Antar, N. A. Ashour, M. Sharaky, M. Khattab, N. A. Ashour, R. T. Zaid, E. J. Roh, A. Elkamhawy, A. A. Al‐Karmalawy, Biomed. Pharmacother. 2023, 168, 115734.
K. Rehman, K. Haider, M. S. H. Akash, Eur. J. Pharmacol. 2021, 909, 174410.
P. Zhu, X. F. Pan, L. Sheng, H. Chen, A. Pan, Curr. Diab. Rep. 2017, 17(9), 78.
M. Śliwińska‐Mossoń, H. Milnerowicz, Diabetes Vasc. Dis. Res. 2017, 14(4), 265.
Y. Liu, L. Lu, H. Yang, X. Wu, X. Luo, J. Shen, Z. Xiao, Y. Zhao, F. Du, Y. Chen, S. Deng, C. H. Cho, Q. Li, X. Li, W. Li, F. Wang, Y. Sun, L. Gu, M. Chen, M. Li, Environ. Pollut. 2023, 339, 122730.
L. Mahmoudzadeh, S. M. Abtahi Froushani, M. Ajami, M. Mahmoudzadeh, Adv. Pharm. Bull. 2023, 13(1), 69.
F. Saaoud, Y. Shao, W. Cornwell, H. Wang, T. J. Rogers, X. Yang, Antioxid. Redox Signal. 2023, 38(13–15), 1041.
N. Kastratovic, V. Markovic, C. R. Harrell, A. Arsenijevic, M. D. Stojanovic, V. Djonov, V. Volarevic, Nicotine. Tob. Res. 2024, 26(6): 704.
C. Y. Kim, K. Lee, C. M. Lee, S. Kim, H. J. Cho, Tob. Induc. Dis. 2022, 20, 20.
M. Znyk, J. Jurewicz, D. Kaleta, Int. J. Environ. Res. Public Health 2021, 18, 6651.
N. Gale, M. McEwan, A. C. Eldridge, I. M. Fearon, N. Sherwood, E. Bowen, S. McDermott, E. Holmes, A. Hedge, S. Hossack, L. Wakenshaw, J. Glew, O. M. Camacho, G. Errington, J. McAughey, J. Murphy, C. Liu, C. J. Proctor, Nicotine. Tob. Res. 2019, 21(9), 1220.
R. S. Surwit, C. M. Kuhn, C. Cochrane, J. A. McCubbin, M. N. Feinglos, Diabetes 1988, 37(9), 1163.
S. Pavlovic, I. Petrovic, N. Jovicic, B. Ljujic, M. Miletic Kovacevic, N. Arsenijevic, M. L. Lukic, Front. Immunol. 2018, 9, 2646.
A. Acovic, B. Simovic Markovic, M. Gazdic, A. Arsenijevic, N. Jovicic, N. Gajovic, M. Jovanovic, N. Zdravkovic, T. Kanjevac, C. R. Harrell, C. Fellabaum, Z. Dolicanin, V. Djonov, N. Arsenijevic, M. L. Lukic, V. Volarevic, Therap. Adv. Gastroenterol. 2018, 11, 175628481879355.
A. Strzelak, A. Ratajczak, A. Adamiec, W. Feleszko, Int. J. Environ. Res. Public Health 2018, 15, 1033.
I. M. Nițulescu, G. Ciulei, A. Cozma, L. M. Procopciuc, O. H. Orășan, J. Clin. Med. 2023, 12(18), 6022.
C. Herder, J. M. Kannenberg, M. Carstensen‐Kirberg, C. Huth, C. Meisinger, W. Koenig, A. Peters, W. Rathmann, M. Roden, B. Thorand, Cardiovasc. Diabetol. 2017, 16(1), 17.
Q. Lu, E. Gottlieb, S. Rounds, Am. J. Physiol. Lung Cell. Mol. Physiol. 2018, 314, L743.
M. Caruso, R. Emma, A. Distefano, S. Rust, K. Poulas, A. Giordano, V. Volarevic, K. Mesiakaris, S. Boffo, A. Arsenijevic, G. Karanasios, R. Pulvirenti, A. Ilic, A. Canciello, P. Zuccarello, M. Ferrante, R. Polosa, G. Li Volti, Drug Test. Anal. 2023, 15, 1164.
Q. Zhang, J. Jeon, T. Goldsmith, M. Black, R. Greenwald, C. Wright, Toxics 2023, 11, 99.
C. N. Uguna, C. E. Snape, ACS Omega 2022, 7, 22111.
M. Becker, S. M. Dirschl, M. G. Scherm, I. Serr, C. Daniel, Cell Metab. 2024, 36(2), 229.
K. Tuomela, M. K. Levings, Diabetologia 2024, 67(4), 611. https://doi.org/10.1007/s00125-023-06076-2
K. C. Herold, T. Delong, A. L. Perdigoto, N. Biru, T. M. Brusko, L. S. K. Walker, Nat. Rev. Immunol. 2024, 24, 435. https://doi.org/10.1038/s41577-023-00985-4
M. B. Ware, B. F. El‐Rayes, G. B. Lesinski, J. Immunother. Cancer 2020, 8(2), e001100.

Auteurs

Nikolina Kastratovic (N)

Department of Genetics, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Genetics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Aleksandar Arsenijevic (A)

Department of Genetics, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Microbiology and Immunology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Carl Randall Harrell (CR)

Department of molecular medicine, Regenerative Processing Plant, Palm Harbor, Florida, USA.

Violeta Mladenovic (V)

Department of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Internal Medicine, Center for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Kragujevac, Kragujevac, Serbia.

Aleksandar Djukic (A)

Department of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Internal Medicine, Center for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Kragujevac, Kragujevac, Serbia.

Ana Volarevic (A)

Department of Genetics, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Psychology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Dalibor Jovanovic (D)

Department of Genetics, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Pathology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

Marija Zdravkovic (M)

Department of Internal Medicine, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Department of Cardiology, University Medical Center "Bežanijska Kosa", Belgrade, Serbia.

Jelica Bjekic Macut (JB)

Department of Endocrinology, University Medical Center "Bežanijska Kosa", Belgrade, Serbia.

Valentin Djonov (V)

Department of Anatomy, Institute of Anatomy, University of Bern, Bern, Switzerland.

Vladislav Volarevic (V)

Department of Genetics, Center for Research on Harmful Effects of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Genetics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Psychology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Department of Genetics, Faculty of Pharmacy Novi Sad, Novi Sad, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH